Hepatitis B virus : a longitudinal study : a thesis presented in partial fulfilment of the requirements for the degree of Masters of Science at Massey University, Palmerston North, New Zealand

dc.contributor.authorBlake-Palmer, Katherine Graciosa
dc.date.accessioned2011-04-05T00:50:39Z
dc.date.available2011-04-05T00:50:39Z
dc.date.issued2002
dc.description.abstractHepatitis B Virus (HBV) is a member of the hepadnavirus family. Viruses from this family infect primate, rodent and avian species. Wild type HBV virions consist of partially double-stranded circular DNA which is converted into covalently closed circular molecules in nuclei upon infection into host cells. The HBV genome is about 3.2kb in size and consists of four transcripts encoding the surface, core, polymerase and X proteins, in overlapping reading frames. HBV infection causes a variety of liver diseases in humans, for example, liver cirrhosis and hepatocellular carcinoma. Clinical manifestations range from asymptomatic to acute. The outcome of acute hepatitis B infection may be influenced by host factors some of which are controlled by the Major Histocompatibility Complex (MHC). In humans the MHC is known as the Human Leukocyte Antigen (HLA) region. Accordingly, the individuals involved in this study were HLA typed. The aim of this study is to investigate HBV DNA differences in three different clinical types of hepatitis B disease over a 15 year period, and to determine if there is a correlation between specific HBV variants and particular clinical states. In 1985, 93% of the population of Kawerau (7,901) was tested for HBV, those found to be positive (519) have been monitored ever since. In 1998, individuals that fitted our requirements were invited to participate in our study. HBV DNA was extracted from blood samples and complete genomes sequenced, over 120,000 nucleotides were sequenced. Differences in HBV genomes sequenced between clinical types and HBV genotypes were compared. HLA alleles between the different clinical types were compared, as well as comparing HBV infected individuals with the general New Zealand population. The overall project is a major one and the results of this thesis get it well underway.en_US
dc.identifier.urihttp://hdl.handle.net/10179/2182
dc.language.isoenen_US
dc.publisherMassey Universityen_US
dc.rightsThe Authoren_US
dc.subjectHepatitis B virusen_US
dc.titleHepatitis B virus : a longitudinal study : a thesis presented in partial fulfilment of the requirements for the degree of Masters of Science at Massey University, Palmerston North, New Zealanden_US
dc.typeThesisen_US
massey.contributor.authorBlake-Palmer, Katherine Graciosaen
thesis.degree.disciplineScienceen
thesis.degree.grantorMassey Universityen
thesis.degree.levelMastersen
thesis.degree.nameMaster of Science (M. Sc.)en
Files
Original bundle
Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
02_whole.pdf
Size:
2.22 MB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
01_front.pdf
Size:
281.92 KB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
03_Appendix A; Tables A.1 to A.3.xls
Size:
284 KB
Format:
Microsoft Excel
Description:
Loading...
Thumbnail Image
Name:
04_Appendix B; Tables B.1 to B.16.xls
Size:
68 KB
Format:
Microsoft Excel
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
804 B
Format:
Item-specific license agreed upon to submission
Description: